With its first PR in 6 years, St. Joseph, Inc (OTC:STJO) is stirring talks among investors bullish on its potential. With plans to venture into the healthcare industry, the company announced it has signed an LOI to merge with RPM Healthcare LLC. Given the potential of this merger and the rapid growth of the industry, STJO saw a major 350% surge in its PPS following the news – positioning itself among the most promising telehealth stocks this week.
STJO Stock News
After being inactive for almost 6 years, STJO is recently gaining momentum as anticipation brews in light of the company’s potential venture into the healthcare industry. On February 16th, the company announced it has signed an LOI to merge with RPM Healthcare LLC – an alternative health and care providing company. Investors are bullish on this agreement which is expected to be finalized as soon as March 15th.
Pursuant to the terms of the agreement, STJO’s current directors will resign and RPM’s leadership team will lead the company’s success in this new venture. Investors are bullish on RPM’s management given their 78 years of combined experience in the healthcare and technology industries. RPM’s CEO – Eric Jensen – has over 36 years of experience in healthcare communications and is well-known for launching Health Monitor Network – a leading patient-education publishing company with the largest physician-requested point-of-care network in the US.
Similarly, RPM’s COO – Mark Jensen – has over 30 years of experience in healthcare communications. In his leading role at Health Monitor Network, Jensen focused on building relationships with professional organizations including 300 thousand physicians along with tens of thousands of nurse practitioners, diabetes educators and physician assistants.
Under their leadership, the company has developed several condition tracking apps including – RA Monitor, Migraine Monitor, Psoriasis Monitor and ITP Monitor. Developed by renowned doctors, these applications help monitor patients’ triggers, symptoms and treatments – which in turn, provides insightful data, in different easy-to-navigate dashboards.
Aside from these applications, the company’s management is most known for successfully introducing the RPM365 platform – which has brought numerous benefits to both patients and healthcare providers that rely on remote monitoring. By using bp monitors, glucometers, pulse oximeters, scales and spirometers, the RPM365 app gathers real-time physiologic data from patients. The app also supports over 50 monitoring devices to ensure convenience and allow patients to be more connected to their health team. Thanks to the platform’s various uses, the company generates an average annual revenue of $1,470 per patient.
To facilitate further growth within the market, RPM has developed several partnerships with a number of leading health condition and professional organizations including National Headache Foundation, Migraine Research Foundation, and National Psoriasis Foundation.
With RPM’s prominent partnerships and solid presence in the healthcare industry, STJO seems poised for growth post-merger. With a market cap under $1 million, STJO has a lot of room to grow among telehealth stocks in the coming months. Infact, STJO’s solid share structure and low float of only 6.7 million could facilitate major run-ups as the company releases more news and updates regarding its highly anticipated ventures.
@MoonMarket_ is bullish on the company’s merger with RPM healthcare
@ShortSqueezed1 is watching STJO and its low float after its first news in almost 6 years!
Following its massive run-up, STJO saw a major fall and is now trading at $.1555 with a primary support at .1005 and secondary support at .0376. The stock shows a newly formed resistance at .3761. The MACD is on a recent bearish crossover and accumulation is on a steep downtrend. Meanwhile, the RSI has cooled off at 51 after being extremely overbought at 80.
This steep downtrend in accumulation could be largely attributed to the increase in investors cashing out for profits following the stock’s recent run-up. Given that the RSI is indicating the stock is stable and the stock is trading near its support, bullish investors could find now a good entry point on STJO before news of its merger sends it on another run to break its current resistance.
STJO Stock Forecast
With a strong management and a profitable merging company, this low float stock is already showing major potential. With this in mind, investors could secure positions on the stock before merger confirmation on March 15th sends the stock on a run. If it does, STJO could be one of the best telehealth stocks in 2022. In light of all these indicators, STJO is shaping up to be a potentially profitable investment with a risk-reward ratio that is skewed towards a buy.
If you have questions about STJO stock and where it could be heading next feel free to reach out to us in our free alerts room!
Please visit and read our disclaimer here.